This white paper examines the challenges and barriers to achieving higher rates of vaccination among Australian adults eligible for the National Immunisation Program (NIP), identifies priority areas for action and suggests evidence-based strategies to improve vaccine coverage rates.
As the world emerges from the pandemic, it is critical
Australia’s national health technology assessment (HTA) processes include the assessment
Discount rates reflect how society values future outcomes compared to
Are you interested in learning more about Biointelect, including our current white paper submissions and health policy related work?
Get in touch with our team to discover how we’re advancing healthcare for all and how you can harness our intellect and proven expertise in bringing innovative life science to market.
Biointelect acknowledges the Traditional Owners and First Nations People of the lands on which we now work and meet. We pay our respects to them and to their elders of yesterday, today, and tomorrow.
Level 4, 143 Macquarie Street, Sydney NSW Australia 2000
ABN 17 154 647 051
Biointelect’s management system has been certified to ISO 9001
Copyright 2025 © Biointelect
